Carevoyance Review 2026

B2B Contact & Company Data

Last updated: 2026-06-03

Visit Carevoyance → See All B2B Data Tools

The Bottom Line

Carevoyance is for medical device and surgical-product sales teams whose entire targeting problem is finding the physicians and facilities with the most relevant procedure volume. If you sell an implant, a surgical tool, or a device tied to specific procedure and diagnosis codes, Carevoyance speaks your language in a way general B2B tools never will. Care clusters, case-loss reports, and referral analytics give reps concrete, claims-backed reasons to be in front of specific surgeons.

The trade-off is focus and uncertainty. The product is medtech-only, so it's the wrong tool for pharma, health IT, or administrator-focused selling. And the January 2024 Definitive Healthcare acquisition raises a real question about Carevoyance's standalone future, plus several users report pricing has climbed since the deal. You're betting on a specialized product inside a larger company that may reshape it over time.

Buy Carevoyance if you run a device sales team and procedure-volume targeting is your core need; nothing else nails that use case as directly. Confirm the roadmap and pricing during your evaluation given the acquisition. Skip it if you're not in medtech: choose Komodo Health for claims-based pharma analytics, IQVIA OneKey for global provider identity, or Definitive Healthcare's full platform if you need broad healthcare commercial intelligence beyond device targeting. For its narrow lane, Carevoyance is one of the strongest options available.

What is Carevoyance?

Carevoyance is a b2b contact & company data tool. Medtech-focused sales intelligence platform. Strong on procedure volume data and surgical targeting. Now part of Definitive Healthcare.

Best for: Medical device and surgical product sales teams targeting by procedure volume

Best For

Medical device and surgical product sales teams targeting by procedure volume

Carevoyance Overview

Carevoyance is a sales-enablement platform built specifically for medical device and medtech companies, and since January 2024 it's been part of Definitive Healthcare. The pitch is narrow on purpose: help device reps find the hospitals and physicians who actually perform the procedures their product touches, then build the targeting and outreach materials around that. Where general B2B tools think in companies and titles, Carevoyance thinks in procedure codes, diagnosis codes, and surgical case volume.

The engine runs on billions of all-payor claims plus other healthcare datasets. Reps build 'care clusters,' which are custom patient cohorts defined by diagnosis and procedure codes with inclusion, exclusion, and time-based logic. From there the platform generates interactive reports showing hospital and physician case volume, market share, case loss (patients leaving a facility for care elsewhere), patient treatment destinations, and referral pathways. For a device rep, that translates directly into 'which surgeons should I be in front of and why.'

Carevoyance also leans into output, not just analysis. It can auto-generate sales materials and account-level reports a rep can take into a meeting, and it pushes data into Salesforce through a plugin so the targeting lives in the CRM reps already use. Being inside Definitive Healthcare now means Carevoyance can connect to a much wider dataset of facilities, physicians, executives, and financials than it had as a standalone startup.

The honest caveats: this is a medtech-only tool, so pharma, health IT, and general healthcare sales teams will find it too narrow. The acquisition makes its standalone roadmap a question mark, since Definitive may fold features into its main platform over time, and several users report that pricing has crept up since the deal. For device teams that target by procedure volume, though, very few tools speak their language this directly.

Pros & Cons

Procedure-volume targeting that device reps actually needCarevoyance is built around surgical and procedure data, so reps can rank physicians and facilities by how often they perform a specific procedure. For a company selling, say, a new orthopedic implant, that means a call list sorted by actual joint-replacement volume rather than a generic specialty filter. This is the core job device sales teams hire it for, and it does it natively where general tools can't.
Care clusters give precise cohort controlThe care-cluster builder lets you define patient populations using diagnosis and procedure codes with inclusion, exclusion, and time-based logic. That precision means you can isolate exactly the patients your device treats and trace where they get care. A team can model a niche indication that a coarse specialty-based tool would never surface, then build territory targeting around the facilities seeing those patients.
Case-loss and referral analytics expose real openingsReports on case loss, patient treatment destinations, and referral pathways show where a hospital is sending patients elsewhere, which is a concrete selling angle. A rep can walk into an account and say 'you're losing this procedure volume to a competitor facility, here's the data.' That kind of insight reframes a sales conversation from product pitch to business problem, and it's hard to replicate without claims data.
Definitive Healthcare data and Salesforce integrationNow inside Definitive Healthcare, Carevoyance can tap a deeper pool of facility profiles, physician records, org charts, and financials than it had alone. The Salesforce plugin pushes targeting and reporting into the CRM reps already work in, so insights don't sit in a separate tool. For teams that want claims-driven targeting connected to their existing pipeline, that combination is genuinely useful.

Standalone future is uncertain post-acquisitionDefinitive Healthcare acquired Carevoyance in January 2024, and acquired products often get folded into the parent platform over time. Buyers should ask directly whether Carevoyance stays a distinct product, gets renamed, or gets absorbed into Definitive's medtech offering. The roadmap uncertainty is a real consideration for a multi-year commitment, even if the current product works well.
Narrow medtech focus limits the audienceCarevoyance is tuned for medical device and surgical-product sales. If you sell pharmaceuticals, health IT, or services to administrators, the procedure-volume framing won't fit, and you'll get more from Komodo Health, IQVIA, or Definitive's broader platform. The specialization that makes it strong for device reps makes it the wrong tool for most other healthcare sales motions.
Pricing has crept up and isn't transparentPricing is custom and quote-only, and multiple users report it has increased since the Definitive acquisition. There's no public starting price, so you can't gauge fit without a sales conversation. Smaller device companies may find the cost harder to justify than they would have when Carevoyance was an independent startup courting that segment.
Claims data has inherent lag and gapsLike any all-payor claims product, the data reflects what was billed and processed, which means a lag of weeks to months and incomplete capture for some payers or cash-pay procedures. Volume rankings are directionally strong but not real-time, and very new procedures or codes may be underrepresented. Reps should treat the numbers as a strong signal, not a live operational feed.

Use Cases

Orthopedic Device Rep Building a Surgeon Target List

A rep selling a new knee-replacement implant needs to know which surgeons in their territory do the most total knee arthroplasties, not just which ones list orthopedics as a specialty. They build a care cluster around the relevant procedure codes and pull a ranked list of surgeons and facilities by case volume. The list surfaces a handful of high-volume surgeons the rep hadn't prioritized and de-emphasizes low-volume names. Instead of cold-calling a broad specialty list, the rep focuses on the 20 surgeons who drive most of the addressable volume, and books meetings backed by each surgeon's actual case data.

Medtech Marketing Team Sizing a New Indication

A medtech company is deciding whether to expand a product into a new clinical indication and needs to know how big the opportunity is. The marketing team uses care clusters to model the patient population by diagnosis and procedure codes, then maps where those patients get treated and which facilities have the highest volume. The analysis shows the addressable market is concentrated in a few hundred hospitals rather than spread thin, which reshapes the launch plan. Field resources get aimed at those accounts from day one, and leadership has claims-backed numbers to support the investment decision.

Capturing Lost Surgical Volume for a Hospital Account

A device rep manages a strategic hospital account and wants to deepen the relationship by helping the hospital grow a service line. Using Carevoyance case-loss and referral reports, the rep shows that the hospital is losing a meaningful share of a specific procedure to a competitor facility 30 miles away. That insight turns into a joint conversation about retaining those cases, which ties directly to the rep's product. The data reframes the rep from vendor to partner, and the account expands its use of the device as the hospital works to recapture the lost procedure volume.

Key Features

Procedure volumes
Physician targeting
Facility analytics
Surgical data
Territory planning
CRM integration

Pricing

Plan	Price
Professional	Custom
Enterprise	Custom

Pricing as of 2026. Check Carevoyance's website for current pricing.

Pricing Analysis

Carevoyance uses custom, quote-only pricing across its Professional and Enterprise tiers, with no public starting figure. Cost depends on how many users you need, the scope of data access, and how deeply you integrate with Salesforce and the wider Definitive Healthcare dataset. Because it's now a Definitive product, pricing conversations often get bundled with Definitive's broader medtech offering rather than sold purely standalone.

Several users report that pricing has increased since the January 2024 acquisition, which tracks with Carevoyance moving from an independent startup chasing the medtech segment to a product inside a larger commercial-intelligence company. Expect a quote in the range typical of healthcare sales-intelligence platforms rather than the low monthly subscriptions of general B2B contact tools. The lack of a published price means you can't self-assess fit; a demo and scoping call are the only way to get a real number.

For budgeting, treat Carevoyance as a team investment justified by procedure-level targeting that general tools can't match. If your device sales motion lives and dies on finding high-volume surgeons and facilities, the claims-driven targeting can pay for itself in better-aimed rep time. If you only occasionally need provider data or your product isn't procedure-specific, the cost is harder to justify and a broader platform or per-record service may fit better.

Frequently Asked Questions

What does Carevoyance do?

Carevoyance is a sales-enablement platform for medtech and medical device companies that helps reps target the hospitals and physicians performing the procedures their product touches. It uses all-payor claims data to rank facilities and surgeons by procedure volume, model patient cohorts with care clusters, and surface case-loss and referral patterns. The goal is to turn claims data into precise, procedure-level targeting for device sales teams.

Is Carevoyance part of Definitive Healthcare?

Yes. Definitive Healthcare acquired Carevoyance in January 2024 and now offers it as a medtech sales-enablement solution within its portfolio. The acquisition gives Carevoyance access to Definitive's larger dataset of facilities, physicians, and executives. It also means buyers should confirm the product roadmap, since acquired tools can eventually be folded into the parent platform.

Who is Carevoyance built for?

It's built specifically for medical device and surgical-product sales and marketing teams that target by procedure volume. The procedure-and-diagnosis-code framing fits device reps who need to find high-volume surgeons and facilities. It's not a good fit for pharma, health IT, or teams selling to administrators, who would get more from Komodo Health, IQVIA, or Definitive's broader platform.

How is Carevoyance different from Definitive Healthcare's main platform?

Definitive Healthcare's core platform is broad healthcare commercial intelligence covering facilities, physicians, claims, org charts, and financials across pharma, medtech, and services. Carevoyance is the medtech-specific layer focused on procedure-volume targeting, care clusters, and automated sales materials for device reps. Since the acquisition, the two increasingly share data, but Carevoyance remains the more specialized, device-focused entry point.

Does Carevoyance integrate with Salesforce?

Yes. Carevoyance offers a Salesforce plugin that pushes its targeting data and reporting into the CRM, so reps can work with claims-driven account intelligence without leaving Salesforce. You keep access to procedure-volume reporting and other features inside the CRM workflow. That integration is part of what makes it usable day to day for device sales teams rather than a separate analytics silo.

Similar Tools

By Rome Thorndike

Reviewed by Rome Thorndike. Last verified 2026-06-03.

Pricing, features, and ratings are based on vendor documentation, public filings, product demos, and feedback from sales teams using these tools in production. We update reviews when vendors ship major releases or change pricing.